High Dose Dexamethasone versus Prednisone as First Line Therapy in Newly diagnosed Immune Thrombocytopenic Purpura in Childre
Phase 3
Recruiting
- Conditions
- Haematological DisordersPaediatrics
- Registration Number
- PACTR202403843973020
- Lead Sponsor
- faculty of medicine of tanta university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children aged 1–18 years with newly diagnosed primary ITP before starting any treatment having platelet count < 30,000 /µ
Exclusion Criteria
1-Patients with secondary ITP including leukemia, drugs, lupus erythematous, hepatitis C, anti-phospholipid syndrome.
2-Ptaients with ITP who received any treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method